Antibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 20661-1-AP - Provider product page

- Provider
- Proteintech Group
- Product name
- Marcks antibody
- Antibody type
- Polyclonal
- Description
- MARCKS antibody (Cat. #20661-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: FC, IF, IHC, IP, WB, ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Cancer biomarkers discovered using pan-cancer plasma proteomic profiling.
Zona pellucida is required for oocyte actin cortex and oocyte-somatic cell interactions during oocyte growth.
Sex specific disruptions in Protein Kinase Cγ signaling in a mouse model of Spinocerebellar Ataxia Type 14.
Enhanced understanding of cinnamaldehyde's therapeutic potential in osteoarthritis through bioinformatics and mechanistic validation of its anti-apoptotic effect.
A peptide against the N-terminus of myristoylated alanine-rich C kinase substrate promotes neuronal differentiation in SH-SY5Y human neuroblastoma cells.
Oncoprotein DJ-1 interacts with mTOR complexes to effect transcription factor Hif1α-dependent expression of collagen I (α2) during renal fibrosis.
Proteomic profile of human dental follicle stem cells and apical papilla stem cells.
Myristoylated alanine-rich C-kinase substrate effector domain phosphorylation regulates the growth and radiation sensitization of glioblastoma.
Bai L, Lyu J, Feng J, Qiao X, Qu Y, Yang G, Zhu Y, Liao L, Gao H, Zang A, Xu Z, Ji T, Ran P, Ding W, Zhang H, Zhu L, Wang Y, Wang L, Wang X, Li Y, Li J, Yin X, Zhao G, Liu D, Gao X, Tian S, Tan S, Pu Y, Li L, Song Z, Song J, Guo W, Liao Y, Ye D, Yang W, Jia Y, Ding C
Nature biomedical engineering 2026 Jan;10(1):16-38
Nature biomedical engineering 2026 Jan;10(1):16-38
Zona pellucida is required for oocyte actin cortex and oocyte-somatic cell interactions during oocyte growth.
Liang S, Xiang W, Quan R, Su J, Lv C, Huang H, Xiao H
Cell death discovery 2026 Apr 20;
Cell death discovery 2026 Apr 20;
Sex specific disruptions in Protein Kinase Cγ signaling in a mouse model of Spinocerebellar Ataxia Type 14.
Wolfe SA, Ma Y, Pilo CA, Chang C, Ghassemian M, Roberts AJ, Lee SR, Gorrie G, Taylor SS, Newton AC
bioRxiv : the preprint server for biology 2025 Feb 10;
bioRxiv : the preprint server for biology 2025 Feb 10;
Enhanced understanding of cinnamaldehyde's therapeutic potential in osteoarthritis through bioinformatics and mechanistic validation of its anti-apoptotic effect.
Sheng Y, Zhai R, Li S, Wang X, Wang Y, Cui Z, Wang C, Wang Q, Zhang Y, Wu C
Frontiers in medicine 2024;11:1448937
Frontiers in medicine 2024;11:1448937
A peptide against the N-terminus of myristoylated alanine-rich C kinase substrate promotes neuronal differentiation in SH-SY5Y human neuroblastoma cells.
Ferdous J, Naitou K, Shiraishi M
The Journal of veterinary medical science 2024 Nov 1;86(11):1136-1144
The Journal of veterinary medical science 2024 Nov 1;86(11):1136-1144
Oncoprotein DJ-1 interacts with mTOR complexes to effect transcription factor Hif1α-dependent expression of collagen I (α2) during renal fibrosis.
Das F, Ghosh-Choudhury N, Maity S, Kasinath BS, Choudhury GG
The Journal of biological chemistry 2022 Sep;298(9):102246
The Journal of biological chemistry 2022 Sep;298(9):102246
Proteomic profile of human dental follicle stem cells and apical papilla stem cells.
Lei T, Zhang X, Chen P, Li Q, Du H
Journal of proteomics 2021 Jan 16;231:103928
Journal of proteomics 2021 Jan 16;231:103928
Myristoylated alanine-rich C-kinase substrate effector domain phosphorylation regulates the growth and radiation sensitization of glioblastoma.
Eustace NJ, Anderson JC, Langford CP, Trummell HQ, Hicks PH, Jarboe JS, Mobley JA, Hjelmeland AB, Hackney JR, Pedersen RT, Cosby K, Gillespie GY, Bonner JA, Willey CD
International journal of oncology 2019 Jun;54(6):2039-2053
International journal of oncology 2019 Jun;54(6):2039-2053
No comments: Submit comment
No validations: Submit validation data